Ningbo MedicalSystem Biotechnology Co Ltd Financial Flexibility Index
Ningbo MedicalSystem Biotechnology Co Ltd financial flexibility index. Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥60.66 Million (operating CF CN¥48.96 Million minus capex CN¥11.70 Million) represents 0% of total liabilities (CN¥706.76 Million). See cash generation quality of Ningbo MedicalSystem Biotechnology Co Lt to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)
Financial flexibility index of Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024. Historical Financial Flexibility Index trend for Ningbo MedicalSystem Biotechnology Co Ltd across 14 annual periods. Check 300439 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Ningbo MedicalSystem Biotechnology Co Ltd Financial Flexibility Index by Year (2011–2024)
Ningbo MedicalSystem Biotechnology Co Ltd financial flexibility index by year from 2011 to 2024. Year-by-year free cash flow to debt coverage for Ningbo MedicalSystem Biotechnology Co Ltd. For the full cash flow conversion analysis, see Ningbo MedicalSystem Biotechnology Co Lt cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | CN¥818.35 Million | CN¥397.81 Million | CN¥771.65 Million | ▼ -9.2% |
| 2023 | 1.17x | CN¥913.90 Million | CN¥633.53 Million | CN¥782.49 Million | ▲ +43.2% |
| 2022 | 0.82x | CN¥867.80 Million | CN¥564.67 Million | CN¥1.06 Billion | ▲ +36.7% |
| 2021 | 0.60x | CN¥717.30 Million | CN¥515.48 Million | CN¥1.20 Billion | ▼ -27.8% |
| 2020 | 0.83x | CN¥1.30 Billion | CN¥912.07 Million | CN¥1.57 Billion | ▲ +101.7% |
| 2019 | 0.41x | CN¥964.37 Million | CN¥601.17 Million | CN¥2.35 Billion | ▲ +10.3% |
| 2018 | 0.37x | CN¥865.02 Million | CN¥418.80 Million | CN¥2.33 Billion | ▲ +160.9% |
| 2017 | 0.14x | CN¥283.79 Million | CN¥-128.40 Million | CN¥1.99 Billion | ▼ -23.2% |
| 2016 | 0.19x | CN¥295.04 Million | CN¥2.45 Million | CN¥1.59 Billion | ▼ -89.0% |
| 2015 | 1.69x | CN¥269.82 Million | CN¥177.55 Million | CN¥159.36 Million | ▲ +83.5% |
| 2014 | 0.92x | CN¥190.15 Million | CN¥116.51 Million | CN¥206.12 Million | ▼ -13.1% |
| 2013 | 1.06x | CN¥172.67 Million | CN¥100.06 Million | CN¥162.59 Million | ▲ +32.2% |
| 2012 | 0.80x | CN¥103.38 Million | CN¥46.78 Million | CN¥128.66 Million | ▼ -31.8% |
| 2011 | 1.18x | CN¥80.54 Million | CN¥49.82 Million | CN¥68.32 Million | — |